在基于HF-ACTION数据的基础上,开发心力衰竭患者生存的诺莫格拉姆预后模型
Ting Cheng1, Dongdong Yu2, Jun Tan1
1Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
BMC medical informatics and decision making
|July 19, 2024
概括
研究人员开发了一种新型的诺莫格拉姆模型,用于预测心力衰竭 (HF) 患者的存活率. 该工具利用年龄,BMI和运动能力等关键因素来改善HF风险评估的临床决策.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
背景情况:
- 心力衰竭 (HF) 生存风险评估是一个关键的研究领域.
- 准确的预后工具对于高频管理中有效的临床决策至关重要.
研究的目的:
- 开发和验证一个简单的,可行的名录模型,用于预测心力衰竭 (HF) 患者的生存率.
- 为了利用心力衰竭-一项对照试验调查运动训练 (HF-ACTION) 研究结果的数据来开发模型.
主要方法:
- 使用来自HF-ACTION数据库的大型HF队列,随机分为培训 (70%) 和验证 (30%) 集.
- 采用多变量考克斯回归来确定名ogram构造的显著预后因素.
- 使用启动重抽样 (1000 次代),交叉验证,一致性指数 (C 指数),校准曲线和决策曲线分析 (DCA) 验证了名录.
主要成果:
- 确定了七个关键的预后因素:年龄,BMI,性别,血压,运动持续时间,VO2峰值和循环利尿剂的使用.
- 在培训队列中达到0.715的C指数,在验证队列中达到0.662的C指数.
- 通过DCA和交叉验证证明了良好的校准和强大的性能,AUC值为365天和730天的生存时间从0.640到0.734.
结论:
- 通过使用大量美国人口,成功开发了一种强大的HF生存预后模型.
- 诺米图提供了宝贵的补充信息,用于预测HF患者的风险.
- 这种工具可以帮助临床医生做出有关HF患者管理的更明智的决定.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:22Heart Failure Drugs: Diuretics
361
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
361
01:20Comparing the Survival Analysis of Two or More Groups
172
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
172